ArticleAntonie van Leeuwenhoek2021
Sphingopyxis microcysteis sp. nov., a novel bioactive exopolysaccharides-bearing Sphingomonadaceae isolated from the Microcystis phycosphere.
Article in Antonie van Leeuwenhoek, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Novel Genomes ofMicroorganisms · 2026Article
- Validation List no. 227: valid publication of new names and new combinations effectively published outside theInternational journal of systematic and evolutionary microbiology · 2026Article
- Effects of Roxithromycin Exposure on the Nitrogen Metabolism and Environmental Bacterial Recruitment ofPlants (Basel, Switzerland) · 2025Article
- Phycobacteria Biodiversity, Selected Isolation, and Bioactivity Elucidation of New Bacterial Species of Highly Toxic Marine DinoflagellateMicroorganisms · 2025Article
- Isolation of Sphingopyxis kveilinensis sp. nov., a Potential Antibiotic-Degrading Bacterium, from a Karst Wetland.Current microbiology · 2024Article
- Taxonomic, Phylogenomic and Bioactivity Profiling of Novel Phycosphere Bacterium from Model CyanobacteriumMarine drugs · 2024Article
- Sphingopyxis lutea sp. nov., a novel moderately halotolerant bacterium isolated from pebbles.Archives of microbiology · 2022Article
- Taxonomic and Bioactivity Characterizations ofMarine drugs · 2022Article
- Characterization of Bioactivities and Biosynthesis of Angucycline/Angucyclinone Derivatives Derived fromMarine drugs · 2021Article
- Maritimibacter alexandrii sp. nov., a New Member of Rhodobacteraceae Isolated from Marine Phycosphere.Current microbiology · 2021Article
- Isolation, Phylogenetic and Gephyromycin Metabolites Characterization of New Exopolysaccharides-Bearing Antarctic Actinobacterium from Feces of Emperor Penguin.Marine drugs · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
During the study into the microbial biodiversity and bioactivity of the Microcystis phycosphere, a new yellow-pigmented, non-motile, rod-shaped bacterium containing polyhydroxybutyrate granules designated as strain Z10-6
Indexed as
Identifiers
33770293What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.